These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35764907)
1. Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis. Gelhard S; Maxwell A; Colman H; Cohen AL; Mendez JS J Neurooncol; 2022 Sep; 159(2):293-300. PubMed ID: 35764907 [TBL] [Abstract][Full Text] [Related]
2. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings? de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma. Kim YR; Cho H; Kim SJ; Chung H; Kook HW; Jang JE; Cheong JW; Kim JS Oncologist; 2024 Jun; 29(6):e796-e802. PubMed ID: 38581718 [TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Wieduwilt MJ; Valles F; Issa S; Behler CM; Hwang J; McDermott M; Treseler P; O'Brien J; Shuman MA; Cha S; Damon LE; Rubenstein JL Clin Cancer Res; 2012 Feb; 18(4):1146-55. PubMed ID: 22228634 [TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission. DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839 [TBL] [Abstract][Full Text] [Related]
7. A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma. Steffanoni S; Calimeri T; Anzalone N; Mastaglio S; Bernardi M; Ferreri AJ Expert Rev Hematol; 2022 Jan; 15(1):33-43. PubMed ID: 34904506 [TBL] [Abstract][Full Text] [Related]
8. Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Batchelor TT; Giri S; Ruppert AS; Geyer SM; Smith SE; Mohile N; Swinnen LJ; Friedberg JW; Kahl BS; Bartlett NL; Hsi ED; Cheson BD; Wagner-Johnston N; Nayak L; Leonard JP; Rubenstein JL Blood Adv; 2024 Jun; 8(12):3189-3199. PubMed ID: 38598710 [TBL] [Abstract][Full Text] [Related]
9. Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study. Houillier C; Ghesquières H; Chabrot C; Soussain C; Ahle G; Choquet S; Nicolas-Virelizier E; Bay JO; Vargaftig J; Gaultier C; Touitou V; Martin-Duverneuil N; Cassoux N; Le Garff-Tavernier M; Costopoulos M; Faurie P; Hoang-Xuan K J Neurooncol; 2017 Jun; 133(2):315-320. PubMed ID: 28432587 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Autologous Stem Cell Transplantation as a Consolidative Strategy for the Treatment of Primary and Isolated Secondary Central Nervous System Diffuse Large B Cell Lymphomas. Sahin U; Gokmen A; Soydan E; Urlu SM; Merter M; Gokgoz Z; Arslan O; Ozcan M Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):e1-e13. PubMed ID: 36344419 [TBL] [Abstract][Full Text] [Related]
11. Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma. Hyung J; Hong JY; Yoon DH; Kim S; Park JS; Park CS; Lee SW; Kim JH; Ryu JS; Huh J; Suh C Ann Hematol; 2019 Jul; 98(7):1657-1664. PubMed ID: 30989325 [TBL] [Abstract][Full Text] [Related]
12. Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients. Sarid N; Bokstein F; Blumenthal DT; Weiss-Meilik A; Gibstein L; Avivi I; Perry C; Ram R J Neurooncol; 2021 Jan; 151(2):211-220. PubMed ID: 33099747 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma. Beca JM; Raza K; Mow E; Keech J; Kouroukis CT Leuk Lymphoma; 2020 May; 61(5):1097-1107. PubMed ID: 31931647 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom. Kassam S; Chernucha E; O'Neill A; Hemmaway C; Cummins T; Montoto S; Lennard A; Adams G; Linton K; McKay P; Davies D; Rowntree C; Easdale S; Eyre TA; Marcus R; Cwynarski K; Fox CP Bone Marrow Transplant; 2017 Sep; 52(9):1268-1272. PubMed ID: 28581466 [TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with newly diagnosed primary CNS lymphoma after high-dose methotrexate followed by consolidation whole-brain radiotherapy and cytarabine: an 8-year cohort study. Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L Int J Clin Oncol; 2021 Oct; 26(10):1805-1811. PubMed ID: 34236556 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
17. Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). Rubenstein JL; Hsi ED; Johnson JL; Jung SH; Nakashima MO; Grant B; Cheson BD; Kaplan LD J Clin Oncol; 2013 Sep; 31(25):3061-8. PubMed ID: 23569323 [TBL] [Abstract][Full Text] [Related]
18. The role of autologous stem cell transplantation in primary central nervous system lymphoma. Ferreri AJ; Illerhaus G Blood; 2016 Mar; 127(13):1642-9. PubMed ID: 26834241 [TBL] [Abstract][Full Text] [Related]
19. Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant. Scordo M; Wang TP; Ahn KW; Chen Y; Ahmed S; Awan FT; Beitinjaneh A; Chen A; Chow VA; Dholaria B; Epperla N; Farooq U; Ghosh N; Grover N; Hamad N; Hildebrandt GC; Holmberg L; Hong S; Inwards DJ; Jimenez-Jimenez A; Karmali R; Kenkre VP; Khimani F; Klyuchnikov E; Krem MM; Munshi PN; Nieto Y; Prestidge T; Ramakrishnan Geethakumari P; Rezvani AR; Riedell PA; Seo S; Shah NN; Solh M; Yared JA; Kharfan-Dabaja MA; Herrera A; Hamadani M; Sauter CS JAMA Oncol; 2021 Jul; 7(7):993-1003. PubMed ID: 33956047 [TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials. Yu J; Du H; Ye X; Zhang L; Xiao H Sci Rep; 2021 Jan; 11(1):2125. PubMed ID: 33483528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]